2.7500
+0.1100
+(4.17%)
At close: April 17 at 4:00:00 PM EDT
2.7500
0.00
(0.00%)
After hours: April 17 at 4:05:06 PM EDT
Breakdown
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Assets
132,737
123,721
152,420
42,609
Total Liabilities Net Minority Interest
11,734
7,549
2,949
16,510
Total Equity Gross Minority Interest
121,003
116,172
149,471
26,099
Total Capitalization
121,003
116,172
149,471
40,067
Common Stock Equity
121,003
116,172
149,471
26,099
Capital Lease Obligations
2,228
2,478
188
452
Net Tangible Assets
121,003
116,172
149,471
26,099
Working Capital
119,047
99,710
149,642
40,025
Invested Capital
121,003
116,172
149,471
40,067
Tangible Book Value
121,003
116,172
149,471
26,099
Total Debt
2,228
2,478
188
14,420
Share Issued
53,246
36,827
33,582
8,352.2770
Ordinary Shares Number
53,246
36,827
33,582
8,352.2770
6/30/2021 - 1/14/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHVS Pharvaris N.V.
14.00
+2.04%
MLYS Mineralys Therapeutics, Inc.
13.35
-1.11%
TRVI Trevi Therapeutics, Inc.
6.07
-0.49%
TECX Tectonic Therapeutic, Inc.
17.02
-3.08%
FHTX Foghorn Therapeutics Inc.
3.8000
+9.51%
CYTK Cytokinetics, Incorporated
39.48
+0.84%
INMB INmune Bio, Inc.
7.32
+0.14%
TBPH Theravance Biopharma, Inc.
8.62
+0.29%
IDYA IDEAYA Biosciences, Inc.
17.08
+5.56%
EPIX ESSA Pharma Inc.
1.7900
+1.13%